Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy

CardioRenal Medicine- Switzerland

doi 10.1159/000342968

Full Text

Abstract

Available in

Date

Authors

Publisher

S. Karger AG


Related search